Abstract:Gene expression changes in nasal and bronchial epithelium, and quantitative features from chest CT reflect the presence of lung cancer in current and former smokers and can serve as biomarkers. Between 10-20% of lung cancer cases are diagnosed in patients who have never smoked (<100 lifetime cigarettes) and biomarkers could assist the diagnosis of pulmonary nodules discovered incidentally in this population. We compared lung cancer-associated gene expression and radiomic features in never-smokers and ever-smokers. Nasal epithelial RNA was isolated and sequenced from brushings collected at UCLA from 73 patients presenting to interventional radiology for biopsy for suspected lung cancer. Limma was used to identify genes with lung cancer-associated expression in never-smokers by comparing 13 patients with benign nodules with 14 patients diagnosed with lung cancer. Similarities between cancer-associated genes in never-smokers and those previously identified in ever-smokers were assessed by gene set enrichment analysis (GSEA). Next, using all 73 samples, genes whose lung cancer-associated expression is modified by smoking status were identified via an interaction term. Radiomic features for 46 patients (31 ever-smokers, 15 never-smokers) were extracted using PyRadiomics, including features from the interior of the nodule and perinodular features generated 10, 15, and 20 mm away from the boundary of the nodule. A binomial model was used to identify features with a significant interaction effect between cancer and smoking status. We identified 74 genes decreased and 84 genes increased in cancer in never-smokers (p < 0.005), controlling for age and median TIN. Genes changed in ever-smoker lung cancer patients were significantly enriched among the genes most associated with lung cancer in never smokers (GSEA; p = 0.0059 and p = 4.38e-15). Next, there were 51 genes with a p-value < 0.01 for the cancer*smoking interaction term. Lastly, four radiomic features were associated with the perinodular term for cancer and smoking status (FDR< 0.2), including two nodular and two boundary features. These results suggest that lung cancer-associated gene expression differences in ever-smokers are preserved in never-smokers, suggesting the potential relevance of previously derived biomarkers for this population. There may also be never-smoker-specific gene expression patterns associated with lung cancer. Our radiomic findings suggest that both nodular and perinodular characteristics may be important predictors of malignancy. Citation Format: Minyi Lee, Anil Yadav, Gang Liu, Steven Dubinett, Jennifer Beane, William Hsu, Ashley Prosper, Denise Aberle, Marc Lenburg. Molecular and radiographic profiling of lung cancer in never-smokers [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 877.

Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Aryl hydrocarbon receptor (AhR)-dependent regulation of pulmonary miRNA by chronic cigarette smoke exposure

Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers

Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers

MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Identification of miRNA Biomarkers for Non-small Cell Lung Cancer using Microarray Datasets and Bioinformatics Analysis

Analyses on Expression of Trimethylation of Histone H3 at Lysine 27 and DNA Methylation at CCGG Sites in Smoking and Nonsmoking Non-Small Cell Lung Cancer Patients and Their Clinical Significance.

Abstract 877: Molecular and radiographic profiling of lung cancer in never-smokers

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival

Microarray analysis of lung long non-coding RNAs in cigarette smoke-exposed mouse model

Analysis of H3K27me3 expression and DNA methylation at CCGG sites in smoking and non-smoking patients with non-small cell lung cancer and their clinical significance.

Differential Protein-Coding Gene and Long Noncoding RNA Expression in Smoking-Related Lung Squamous Cell Carcinoma

Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.

Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis

[Expression and Prognosis Effect of Methylation-Regulated SLIT3 and SPARCL1 Genes in Smoking-Related Lung Adenocarcinoma].

Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis

MicroRNA and Mrna Interaction Network Regulates the Malignant Transformation of Human Bronchial Epithelial Cells Induced by Cigarette Smoke